JnJ closes Intra-Cellular Therapies acquisition Ruchika Sharma3 April 2025 10:30 AM ISTNew Brunswick: Johnson & Johnson has announced it has completed its acquisition of Intra-Cellular Therapies, Inc. Intra-Cellular Therapies is...
Can Metformin Counteract Antipsychotic-Induced Hyperprolactinemia? New Evidence Emerges Medha Baranwal28 March 2025 8:30 PM ISTTaiwan: A recent meta-analysis of randomized controlled trials has highlighted the potential of metformin in reducing antipsychotic-induced...
Medical Bulletin 03/ March/ 2025 Dr. Bhumika Maikhuri3 March 2025 3:00 PM ISTHere are the top medical news for the day:Nasal Spray Innovation Offers Hope for Traumatic Brain Injury TreatmentA new study led by researchers at...
Survey Highlights Preference for Non-Invasive Treatments Over Medication in Mental Health Care Rishabh Verma3 March 2025 8:15 AM ISTA new study, led by experts at the University of Nottingham, has found that patients who need treatment for neurological and mental health disorders,...
Medical Bulletin 01/ March/ 2025 Dr. Bhumika Maikhuri1 March 2025 3:00 PM ISTHere are the top medical news for the day:Continuous Glucose Monitoring can Overestimating Your Blood Sugar Levels, Study findsContinuous Glucose...
New Study Reveals Schizophrenia's Impact on Brain Structure Dr. Bhumika Maikhuri1 March 2025 8:15 AM ISTThe symptoms of schizophrenia vary greatly from person to person. A new study shows how these differences manifest themselves in the structure of the...
Multiple sclerosis drug may help with poor working memory: Study Dr. Kamal Kant Kohli26 Feb 2025 8:30 PM ISTFampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced...
AI may aid in the timely diagnosis of schizophrenia and bipolar disorder, suggests research Dr. Kamal Kant Kohli25 Feb 2025 9:00 PM ISTSchizophrenia and bipolar disorder are severe mental disorders that often manifest in early adulthood. Effective treatments exist, but they require an...
Machine Learning Model Predicts Schizophrenia More Accurately Than Bipolar Disorder: JAMA Dr Riya Dave24 Feb 2025 8:15 PM ISTA new study has found that machine learning algorithms can forecast the progression of schizophrenia and bipolar disorder from typical clinical...
Xanomeline and trospium chloride Improves Cognition in Schizophrenia With Baseline Impairments, reveals study Dr Riya Dave20 Jan 2025 9:30 PM ISTXanomeline and trospium chloride (KarXT), a novel M1/M4 muscarinic receptor agonist, significantly improves cognitive performance among patients with...
Boehringer Ingelheim's Schizophrenia Drug iclepertin Fails Phase 3 Trial Dr. Kamal Kant Kohli19 Jan 2025 8:15 PM ISTBoehringer Ingelheim announced that its schizophrenia drug, iclepertin, did not achieve statistically significant improvements in cognition or...
Alembic Pharma bags USFDA final approval for schizophrenia drug Brexpiprazole Ruchika Sharma15 Jan 2025 1:30 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug Administration (USFDA)...
